PRESCRIPTION DRUG "REMINDER AD" AND PREAPPROVAL AD POLICIES ARE BEING RE-EVALUATED BY FDA; AGENCY HAS ISSUED 10 TO 15 LETTERS FOR VIOLATIVE REMINDER ADS